D-0473-2025 Class II Ongoing
FDA drug recall D-0473-2025 was initiated by Teva Pharmaceuticals USA, Inc on May 23, 2025 and is designated Class II. Reason for recall: Presence of foreign tablets/capsules. The recall status is ongoing. Affected quantity: 36612 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 2, 2025
- Initiation Date
- May 23, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 36612 cartons
Product description
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.
Reason for recall
Presence of foreign tablets/capsules.
Distribution pattern
USA Nationwide
Code information
Lot#: 5420094, Exp 09/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0473-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026